Matches in Wikidata for { <http://www.wikidata.org/entity/Q69489505> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q69489505 description "artikull shkencor i botuar më 01 shkurt 1989" @default.
- Q69489505 description "artículu científicu espublizáu en febreru de 1989" @default.
- Q69489505 description "bài báo khoa học" @default.
- Q69489505 description "im Februar 1989 veröffentlichter wissenschaftlicher Artikel" @default.
- Q69489505 description "scientific article published on 01 February 1989" @default.
- Q69489505 description "wetenschappelijk artikel" @default.
- Q69489505 description "наукова стаття, опублікована в лютому 1989" @default.
- Q69489505 name "Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial" @default.
- Q69489505 name "Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial" @default.
- Q69489505 name "Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial" @default.
- Q69489505 type Item @default.
- Q69489505 label "Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial" @default.
- Q69489505 label "Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial" @default.
- Q69489505 label "Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial" @default.
- Q69489505 prefLabel "Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial" @default.
- Q69489505 prefLabel "Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial" @default.
- Q69489505 prefLabel "Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial" @default.
- Q69489505 P1433 Q69489505-B500080D-1434-4D6C-A44A-0A925397068D @default.
- Q69489505 P1476 Q69489505-BD8847DF-C85D-433F-8CE6-35FEC0F058B4 @default.
- Q69489505 P2093 Q69489505-217169A3-F413-4D92-9D31-F3C3AADBF768 @default.
- Q69489505 P2093 Q69489505-2F40D3BC-E0F7-4685-9890-C3FBDFFACDA9 @default.
- Q69489505 P2093 Q69489505-3913612F-7AC5-403C-8A0B-8449D10AB44D @default.
- Q69489505 P2093 Q69489505-4003A79A-F97F-4884-B020-BDEC006A5220 @default.
- Q69489505 P2093 Q69489505-5E3C1FC7-1818-4905-B29C-72F3303F9F55 @default.
- Q69489505 P2093 Q69489505-C7A3BBCB-55B5-4EB7-9571-EB12C71EF0BF @default.
- Q69489505 P2093 Q69489505-CA363618-67E7-4B4A-A297-36399E8487AC @default.
- Q69489505 P2093 Q69489505-D82A894B-11FA-4874-B2E3-7A1350EA11E8 @default.
- Q69489505 P2093 Q69489505-E6194EF4-8027-4B5A-BF55-74AD2331B23D @default.
- Q69489505 P2093 Q69489505-FC1FFAE1-077A-4C50-A2BB-88210C200DB1 @default.
- Q69489505 P304 Q69489505-D622E2FB-B282-4A86-A574-2639BCD29DA5 @default.
- Q69489505 P31 Q69489505-B47901BC-B0B8-4B92-8002-4B9A7C2A6406 @default.
- Q69489505 P356 Q69489505-12E49195-2078-4627-A999-CA2634204943 @default.
- Q69489505 P433 Q69489505-CECAB671-0F97-4822-A56B-247A482A0E12 @default.
- Q69489505 P478 Q69489505-57565D9A-F3D0-4148-B034-018A4DC06A33 @default.
- Q69489505 P577 Q69489505-ADEB3437-EFF5-4523-8AC8-8810D30227E0 @default.
- Q69489505 P698 Q69489505-9F327F4A-F889-4EFE-B500-55B39A30DAC9 @default.
- Q69489505 P921 Q69489505-19DB1EF3-FE3F-4CBC-9F83-91B994A08114 @default.
- Q69489505 P921 Q69489505-864DA474-B93F-485C-B6F1-B04AEDEA72C3 @default.
- Q69489505 P921 Q69489505-CC2ABF96-D74E-4272-B2C9-4120FC87865B @default.
- Q69489505 P356 OXFORDJOURNALS.EURHEARTJ.A059456 @default.
- Q69489505 P698 2647494 @default.
- Q69489505 P1433 Q2286839 @default.
- Q69489505 P1476 "Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial" @default.
- Q69489505 P2093 "A Arís" @default.
- Q69489505 P2093 "C Castellarnau" @default.
- Q69489505 P2093 "C Crexells" @default.
- Q69489505 P2093 "J Altimiras" @default.
- Q69489505 P2093 "J Bonal" @default.
- Q69489505 P2093 "J M Augé" @default.
- Q69489505 P2093 "J M Caralps" @default.
- Q69489505 P2093 "M Masotti" @default.
- Q69489505 P2093 "P Guiteras" @default.
- Q69489505 P2093 "T Bassons" @default.
- Q69489505 P304 "159-167" @default.
- Q69489505 P31 Q13442814 @default.
- Q69489505 P356 "10.1093/OXFORDJOURNALS.EURHEARTJ.A059456" @default.
- Q69489505 P433 "2" @default.
- Q69489505 P478 "10" @default.
- Q69489505 P577 "1989-02-01T00:00:00Z" @default.
- Q69489505 P698 "2647494" @default.
- Q69489505 P921 Q108853737 @default.
- Q69489505 P921 Q18216 @default.
- Q69489505 P921 Q269829 @default.